| Date | Title | Description |
| 10.09.2026 | restor3d Extends Personalized Orthopedics With MyFit Digital Suite | restor3d, a specialist in 3D printed personalized orthopedic solutions, launched MyFit by restor3d Digital Suite on September 8, 2026, a new patient engagement platform designed to give orthopedic implant patients visibility into their trea... |
| 18.08.2026 | Onkos Surgical’s 3D printed My3D pelvic platform crosses 1,000 surgical cases | Onkos Surgical has completed the 1,000th case using its personalized, 510(k) cleared My3D patient-specific pelvic implant platform. The count covers pelvic reconstructions in which a 3D printed implant was designed specifically for the indi... |
| 08.01.2025 | Onkos Surgical Receives $35M Venture Loan Facility | Onkos Surgical, a Parsippany, NJ-based company developing technologies for the musculoskeletal space, received $35M in Venture Loan Facility from Horizon Technology Finance Corporation (NASDAQ: HRZN).
Led by CEO Patrick Treacy, Onkos Surgic... |
| 20.06.2024 | MCRA Supports Onkos Surgical with First FDA De Novo Approval for Antibacterial Coating for Implants | WASHINGTON, June 20, 2024 /PRNewswire/ -- MCRA, the leading privately held independent medical device, diagnostics, and biologics Clinical Research Organization (CRO) and advisory firm is pleased to announce its role in the U.S. Food and Dr... |
| 08.04.2024 | Onkos Surgical Announces First FDA De Novo Approval of an Antibacterial Coating for Tumor and Revision Orthopaedic Implants | - Bacterial contamination of orthopaedic implants is a growing clinical challenge that burdens the healthcare system and can lead to dangerous, potentially fatal complications for patients.
PARSIPPANY, N.J., April 8, 2024 /PRNewswire/ -- On... |
| 08.04.2024 | Onkos Surgical Announces First FDA De Novo Approval of an Antibacterial Coating for Tumor ... | - |
| 03.09.2021 | Onkos Surgical Scores $15M in Series C |
PARSIPPANY, NJ, Onkos Surgical, a developer of solutions for musculoskeletal oncology and orthopaedic procedures, has raised $15M in Series C funding
>> Click here for more funding data on Onkos Surgical
>> To export Onkos S... |
| 02.09.2021 | Sequoia backs a podcasting-focused, Clubhouse competitor from David Sacks | David Sacks, who cofounded Yammer and sold it to Microsoft for about $1.2 billion in 2012, is launching his next startup.
On Thursday, the former Zenefits CEO announced the official launch of Callin, his live-audio, podcasting-focused start... |
| 02.09.2021 | Sequoia backs a podcasting-focused, Clubhouse competitor from David Sacks | David Sacks, who cofounded Yammer and sold it to Microsoft for about $1.2 billion in 2012, is launching his next startup.
Paid Content Why the Electricity 4.0 moment is here From Schneider Electric
On Thursday, the former Zenefits CEO annou... |
| 01.09.2021 | Onkos Surgical Raises $15 Million in Series C Funding | - |
| 01.09.2021 | Onkos Surgical Raises $15 Million in Series C Funding | |
| 01.09.2021 | Onkos Surgical Raises $15M in Series C Funding | Onkos Surgical, a Parsippany, NJ-based provider of surgical solutions for musculoskeletal oncology and orthopaedics, raised $15M in Series C funding.
The backers – part of an existing investor syndicate – were not disclosed.
The company int... |
| 22.06.2021 | Onkos Surgical Announces FDA 510(k) Clearance of its BioGrip® Modular Porous Collars, a First-of-Its-Kind Solution to Help Address Implant Loosening in Orthopaedic Oncology and Complex Revision Surger... | |
| 14.03.2019 | Onkos Surgical to use Promimic’s nano-thin HA coating | Onkos Surgical, a surgical oncology device developer, said today that it is working with Promimic AB to commercialize Promimic’s nano-thin hydroxyapatite coating technology for use on limb salvage surgery implants.
Hydroxyapatite (HA) is a ... |
| 12.02.2018 | Philly healthcare and life science investment firm 1315 Capital raises $300M+ for second fund | Among its portfolio companies are Geneoptix, an oncology molecular diagnostics business; Innovative Health seeks to reduce costs for reprocessing single-use medical devices; and orthopedic oncology business Onkos Surgical.
Founding partner ... |
| 19.04.2017 | Term Sheet — Wednesday, April 19 | M&A ACTION
Mega M&A: Verizon hasn’t exactly been on the sidelines when it comes to splashy M&A (Yahoo, AOL, Vessel, Fleetmatics…), but CEO Lowell McAdam may still be itching for something more. (Perhaps he hasn’t won enough awar... |
| 19.04.2017 | Canaan Partners Leads $17.6M Series B for Onkos Surgical | Onkos Surgical, Inc., a specialty medtech company focused on surgical oncology, today announced that it closed a $17.6 million round in Series B funding. Canaan Partners led the funding round and existing investors 1315 Capital and 3D Syste... |
| 19.04.2017 | Onkos Surgical Raises $17.6M Series B | Onkos Surgical, Inc., a specialty medtech company focused on surgical oncology, today announced that it closed a $17.6 million round in Series B funding. Canaan Partners led the funding round and existing investors 1315 Capital and 3D Syste... |
| 19.04.2017 | Onkos Surgical’s “specialty medtech” model attracts a $17.6M Series B | While it has some solid partnerships and a new $17.6 million Series B financing round under its belt, how can it possibly compete?
The tactic, according to CEO Patrick Treacy, is specialization. Onkos isn’t taking on Goliath, it’s just taki... |
| 19.04.2017 | Onkos Surgical Closes $17.6M Series B Funding Round | Onkos Surgical, Inc., a Pasipanny, NJ-based specialty medtech company focused on surgical oncology, closed a $17.6m Series B funding round.
The round was led by Canaan Partners with participation from existing investors 1315 Capital and 3D ... |
| 19.04.2017 | Onkos Surgical Secures $17.6M in Series B |
PARSIPPANY, NJ, Specialty medtech company focused on surgical oncology, today announced that it closed a $17.6 million round in Series B funding.
>> Click here for more funding data on Onkos Surgical
>> To export Onkos Surgi... |
| 15.06.2016 | PE firm 1315 Capital raises $200M fund to invest in health tech, life sciences | What specific health technology trends spark your interest? We believe there is a significant opportunity in the smaller end of healthcare growth equity where Michael Koby and I have spent the vast majority of our investing careers. Massive... |
| 06.10.2015 | Onkos Surgical Closes Series A Financing | Onkos Surgical, a Parsipanny, NJ-based surgical oncology startup, closed a Series A round of financing.
The amount of the deal was not disclosed.
The round was led by 1315 Capital.
Founded in 2015 by CEO Patrick Treacy, Antony Koblish and 1... |
| - | Philly healthcare and life science investment firm 1315 Capital raises $300M+ for second fund | A Philadelphia venture capital firm 1315 Capital, which focuses on early to mid-stage investments primarily for pharma and medtech companies, has made the first close for its second fund, raising more than $300 million.
The firm’s fund 1315... |
| - | PE firm 1315 Capital raises $200M fund to invest in health tech, life sciences | Philadelphia private equity firm 1315 Capital has raised $200 million for its first fund targeting health tech, life sciences and healthcare services investments. Its investors include endowments, foundations, state and corporate pension fu... |
| - | Onkos Surgical’s “specialty medtech” model attracts a $17.6M Series B | It’s an interesting take on the David vs. Goliath battle.
Founded in 2015, Parsippany, New Jersey-based Onkos Surgical is trying to penetrate an orthopedic device market dominated by industry giants such as Stryker and Biomet.
While it has ... |
| - | Onkos Surgical | “Home - Onkos Surgical” |
